Publication date: Jun 09, 2025
He is the inventor of the Centivax Universal Vaccine technology, the SuperHuman discovery library technology, and the Tumbler technology. During that period, he developed the core business model, the research teams, and the technologies that enabled Distributed Bio to become profitable without investment. He built and sold his first company Distributed Bio from founding in March of 2012 to a 104M dollar sale to Charles River Laboratories in December of 2020. Jacob GLanville, PhD Jacob Glanville is a serial entrepreneur, and computational immuno-engineer.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | cell |
| pathway | REACTOME | Translation |
| disease | MESH | autoimmunity |
| disease | IDO | pathogen |
| disease | MESH | COVID-19 |
| disease | IDO | facility |
| pathway | KEGG | Asthma |
| pathway | REACTOME | Adaptive Immune System |
| disease | MESH | Allergy |
| disease | MESH | Asthma |
(Visited 1 times, 1 visits today)